Functional magnetic resonance imaging demonstrated changes in brain function and cognitive performance in patients with relapse-remitting multiple sclerosis following a cognitive rehabilitation program.
Functional magnetic resonance imaging (fMRI) demonstrated changes in brain function and cognitive performance in patients with relapse-remitting multiple sclerosis (MS) after they participated in a cognitive rehabilitation program, Italian researchers found. Their study was published today in the journal Radiology.
The small study from the San Raffaele Vita-Salute University in Milan involved 20 patients with MS. Along with many physical symptoms, MS also can cause memory loss and other cognitive effects. Ten patients were controls and the other 10 were assigned to a 12-week computer-assisted cognitive rehabilitation program that worked on attention and information processing, and executive functions.
All 20 patients underwent baseline neuropsychology assessments and fMRI; this was repeated after 12 weeks. Among the patients who participated in the rehabilitation program, the researchers found changes in activity in several brain regions that were not seen in the controls. The researchers did not, however, find any structural changes in the gray matter or normal-appearing with matter.
“The findings demonstrated that computer-assisted cognitive rehabilitation in patients with MS results in an improvement of the trained cognitive functions,” said the study’s lead author, Massimo Filippi, MD. “However, the structural integrity of the brain’s gray matter and white matter showed no modifications in these patients, suggesting an impairment of structural plasticity.”
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
Study: AI-Generated ADC Maps from MRI More Than Double Specificity in Prostate Cancer Detection
June 5th 2025Emerging research showed that AI-generated ADC mapping from MRI led to significant increases in accuracy, PPV and specificity in comparison to conventional ADC mapping while achieving a 93 percent sensitivity for PCa.